Literature DB >> 8120380

A peptide antigen antagonist prevents the differentiation of T cell receptor transgenic thymocytes.

L M Spain1, J L Jorgensen, M M Davis, L J Berg.   

Abstract

The developmental fate of an immature T cell is determined in the thymus. Depending on the specificity of its TCR, a thymocyte receives signals to either die or differentiate. We have used fetal thymic organ cultures derived from TCR transgenic mice to examine the role of MHC/peptide ligands in T cell selection. Single amino acid substituted peptide analogues of the Ag recognized by the transgenic TCR were examined for their ability to enhance or interfere with positive selection. We have identified a nonstimulatory peptide analogue that interferes with the differentiation of transgenic CD4+8+ thymocytes into CD4+8- cells. We also show that this peptide, substituted in a TCR contact residue, is a competitive antagonist for activation of the T cell hybridoma expressing the same TCR. These observations demonstrate a novel mechanism for tolerance induction in the thymus.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8120380

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  25 in total

Review 1.  Fetal thymic organ culture in rotating bioreactors.

Authors:  B Tabourn; L M Spain
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999-01       Impact factor: 2.416

2.  Dissociation of peripheral T cell responses from thymocyte negative selection by weak agonists supports a spare receptor model of T cell activation.

Authors:  Lisa K McNeil; Brian D Evavold
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

3.  Altered positive selection due to corecognition of floppy peptide/MHC II conformers supports an integrative model of thymic selection.

Authors:  Christophe Viret; Xin He; Charles A Janeway
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-16       Impact factor: 11.205

Review 4.  Defining the parameters necessary for T-cell recognition of ligands that vary in potency.

Authors:  Neely E Kilgore; Mandy L Ford; Carrie D Margot; Daniel S Jones; Peter Reichardt; Brian D Evavold
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

Review 5.  T cell receptor antagonism in vivo, at last.

Authors:  S C Jameson
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

6.  On the issue of peptide recognition in T cell development.

Authors:  Travis J Crites; Rajat Varma
Journal:  Self Nonself       Date:  2010-01

7.  The in vivo mechanism of action of CTLA4Ig.

Authors:  T A Judge; A Tang; L M Spain; J Deans-Gratiot; M H Sayegh; L A Turka
Journal:  J Immunol       Date:  1996-03-15       Impact factor: 5.422

8.  Interactions with multiple peptide ligands determine the fate of developing thymocytes.

Authors:  O Williams; R Tarazona; A Wack; N Harker; K Roderick; D Kioussis
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

9.  Inhibition of intrathymic T cell development by expression of a transgenic antagonist peptide.

Authors:  C N Levelt; E Mizoguchi; X Huang; R Zacks; A K Bhan; S Tonegawa
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

10.  HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites.

Authors:  Milton D Rossman; Bruce Thompson; Margaret Frederick; Mary Maliarik; Michael C Iannuzzi; Benjamin A Rybicki; Janardan P Pandey; Lee S Newman; Eleni Magira; Bojana Beznik-Cizman; Dimitri Monos
Journal:  Am J Hum Genet       Date:  2003-08-20       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.